ADVERSE REACTIONS
The following adverse reactions are discussed in greater detail in other sections of the label:
• Hepatitis B reactivation [see Warnings and Precautions (5.1)]
• Progressive multifocal leukoencephalopathy [see Warnings and Precautions (5.2)]
• Infusion reactions [see Warnings and Precautions (5.3)]
• Tumor lysis syndrome [see Warnings and Precautions (5.4)]
• Infections [see Warnings and Precautions (5.5)]
• Neutropenia [see Warnings and Precautions (5.6)]
• Thrombocytopenia [see Warnings and Precautions (5.7)]